NEKTAR THERAPEUTICS
NKTR
17 insider filings · Latest: Sep 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Aug 20 11:05 PM | Jonathan ZalevskyChief R&D Officer | Sale | 186 | $71.98 | $13.4K | 9,570(D) | View → |
| Aug 18, 2026 | Aug 20 11:03 PM | Howard W RobinDirector, President & CEO | Sale | 418 | $71.98 | $30.1K | 54,627(D) | View → |
| Aug 18, 2026 | Aug 18 7:57 PM | Zalevsky Jonathan | Proposed Sale | 186 | $71.98 | $13.4K | — | View → |
| Aug 18, 2026 | Aug 18 7:42 PM | ROBIN HOWARD W | Proposed Sale | 418 | $71.98 | $30.1K | — | View → |
| Jun 30, 2026 | Jul 2 11:06 PM | Jonathan ZalevskyChief R&D Officer | Sale | 5,681 | $70.00 | $397.7K | 9,756(D) | View → |
| Jun 30, 2026 | Jun 30 8:36 PM | JONATHAN ZALEVSKY | Proposed Sale | 5,681 | $65.39 | $371.5K | — | View → |
| Jun 17, 2026 | Jun 18 11:08 PM | Howard W RobinDirector, President & CEO | Sale | 10,000 | $61.19 | $611.9K | 55,045(D) | View → |
| Jun 16, 2026 | Jun 18 11:08 PM | Howard W RobinDirector, President & CEO | Sale | 10,000 | $60.32 | $603.2K | 65,045(D) | View → |
| Jun 15, 2026 | Jun 17 11:12 PM | Jonathan ZalevskyChief R&D Officer | Sale | 5,538 | $60.71 | $336.2K | 15,437(D) | View → |
| Jun 17, 2026 | Jun 17 3:05 PM | ROBIN HOWARD W | Proposed Sale | 10,000 | $60.27 | $602.7K | — | View → |
| Jun 16, 2026 | Jun 16 3:07 PM | ROBIN HOWARD W | Proposed Sale | 10,000 | $60.96 | $609.6K | — | View → |
| Jun 15, 2026 | Jun 15 8:56 PM | JONATHAN ZALEVSKY | Proposed Sale | 5,538 | $59.38 | $328.8K | — | View → |
| May 19, 2026 | May 21 10:26 PM | Jonathan ZalevskyChief R&D Officer | Sale | 199 | $65.51 | $13.0K | 20,975(D) | View → |
| May 19, 2026 | May 21 10:26 PM | Howard W RobinDirector, President & CEO | Sale | 444 | $65.51 | $29.1K | 75,045(D) | View → |
| May 19, 2026 | May 19 7:27 PM | Zalevsky Jonathan | Proposed Sale | 199 | $65.51 | $13.0K | — | View → |
| May 19, 2026 | May 19 7:24 PM | ROBIN HOWARD W | Proposed Sale | 444 | $65.51 | $29.1K | — | View → |
| Mar 13, 2026 | Mar 13 5:04 PM | Wilson Mark Andrew | Proposed Sale | 78,510 | $72.64 | $5.7M | — | View → |
| Feb 18, 2026 | Feb 21 12:10 AM | Jonathan ZalevskyChief R&D Officer | Sale | 180 | $73.00 | $13.1K | 21,174(D) | View → |
| Feb 18, 2026 | Feb 21 12:10 AM | Howard W RobinDirector, President & CEO | Sale | 423 | $73.00 | $30.9K | 75,489(D) | View → |
| Feb 18, 2026 | Feb 18 8:47 PM | ROBIN HOWARD W | Proposed Sale | 423 | $73.00 | $30.9K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Sep 26 12:29 AM | Roy A WhitfieldDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:26 AM | Scott R GreerDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:22 AM | Robert ChessDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:20 AM | Diana BrainardDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:18 AM | Jeffrey Robert AjerDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Jul 24, 2026 | Jul 24 10:35 PM | Jonathan ZalevskyChief R&D Officer | Grant/Award | 16,500 | $15.15 | 16,500(D) | View → |
| Jul 24, 2026 | Jul 24 10:34 PM | Howard W RobinDirector, President & CEO | Grant/Award | 57,200 | $15.15 | 57,200(D) | View → |